KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Return on Assets (2018 - 2025)

Historic Return on Assets for Aquestive Therapeutics (AQST) over the last 8 years, with Q3 2025 value amounting to 0.54%.

  • Aquestive Therapeutics' Return on Assets fell 2300.0% to 0.54% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.54%, marking a year-over-year decrease of 2300.0%. This contributed to the annual value of 0.56% for FY2024, which is 4200.0% down from last year.
  • Per Aquestive Therapeutics' latest filing, its Return on Assets stood at 0.54% for Q3 2025, which was down 2300.0% from 0.66% recorded in Q2 2025.
  • In the past 5 years, Aquestive Therapeutics' Return on Assets registered a high of 0.13% during Q4 2023, and its lowest value of 1.31% during Q3 2022.
  • Over the past 5 years, Aquestive Therapeutics' median Return on Assets value was 0.56% (recorded in 2023), while the average stood at 0.68%.
  • Per our database at Business Quant, Aquestive Therapeutics' Return on Assets surged by 11000bps in 2023 and then plummeted by -4600bps in 2025.
  • Quarter analysis of 5 years shows Aquestive Therapeutics' Return on Assets stood at 1.11% in 2021, then grew by 10bps to 1.0% in 2022, then skyrocketed by 87bps to 0.13% in 2023, then crashed by -210bps to 0.42% in 2024, then decreased by -28bps to 0.54% in 2025.
  • Its last three reported values are 0.54% in Q3 2025, 0.66% for Q2 2025, and 0.53% during Q1 2025.